479
Participants
Start Date
June 17, 2021
Primary Completion Date
May 18, 2023
Study Completion Date
November 16, 2023
CT-P41
60 mg/mL single dose, Solution for injection in PFS
US-licensed Prolia
60 mg/mL single dose, Solution for injection in PFS
Health Center 4-117 K. Barona Str, Riga
Health Center Association, Medical Center Liepaja, Liepāja
Center For Clinical And Basic Research, Tallinn
East Tallinn Central Hospital-Ravi 18, Tallinn
Clinic of SRI of Invalid Rehab. (ESTC) of VNMU n.a. M.I.Pyrohov, Vinnytsia
Clinical Research Centre Ltd, Tartu
KLV Arstikabinet, Pärnu
AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Poznaniu, Poznan
Centrum Medyczne Poznan - PRATIA - PPDS, Skórzewo
Krakowskie Centrum Medyczne, Krakow
AES - DRS - Synexus Polska Sp. z o.o. Oddzial we Wroclawiu, Wroclaw
SOMED CR Sp. z o.o. Sp. Komandytowa - Lodz, Lódz
AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warsaw
SOMED CR Sp. z o.o. Sp. Komandytowa - Warszawa, Warsaw
NZOZ Osteo Medic SC Artur Racewicz Jerzy Supronik, Bialystok
AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia
MCM Krakow - PRATIA - PPDS, Krakow
AES - AS - Medical Center of Edelweiss Medics LLC, Kyiv
Clinic of SI Institute of Gerontology n.a. D.F.Chebotaryov of NAMS of Ukraine, Kyiv
AES - AS - Medical Center of Medbud - Clinic LLC, Kyiv
Lead Sponsor
Celltrion
INDUSTRY